Innocyte GmbH

Innocyte GmbH is a domain name marketplace specializing in the sale and transfer of web domains, aiming to streamline online presence acquisition for individuals and businesses alike. Founded in 2011 and headquartered in Stuttgart, Germany, Innocyte GmbH operates a platform that facilitates domain name transactions. The company has undergone no notable pivots during its operations and does not currently have any subsidiaries. The firm raised an undisclosed amount in a Seed round in November 2012, targeting investments to enhance its service offerings.

The founder's background is not specified, and there are no previous companies indicated. Innocyte. com primarily operates as a domain name marketplace, offering a streamlined service for the purchase and transfer of web domains. Their core product is the sale of premium domain names, with a notable example being innocyte.

com, which is listed at a price of USD 3,888. The platform aims to simplify the domain acquisition process for various users, including entrepreneurs, businesses, and individuals seeking to establish an online presence. The service encompasses free transaction support, secure payment options, and the ability to conduct transactions in local currencies, catering to a diverse global clientele. The company's offerings are tailored to customers across multiple geographical markets, including North America, Europe, and Asia, reflecting a broad appeal to both local and international buyers.

Innocyte. com generates revenue primarily through the sale of domain names, with transactions structured around direct sales to consumers. When a client expresses interest in purchasing a domain, they are presented with a clear pricing structure, such as the listed price of USD 3,888 for innocyte. com.

Payment is facilitated through secure and hassle-free methods, ensuring a smooth transaction process. The company also provides ongoing support, which contributes to customer satisfaction and potentially encourages repeat business. By focusing on the straightforward acquisition of digital assets, Innocyte. com positions itself effectively within the domain marketplace, catering to a varied customer base that includes businesses looking to enhance their online identity.

Innocyte GmbH plans to develop and launch new products aimed at enhancing its service offerings, though specific details and release dates are not disclosed. The company is targeting expansion into new markets in Europe and Asia by the end of 2023. The funds raised during the Seed round in November 2012 will be utilized to support these initiatives, focusing on technological enhancements and marketing strategies to reach a broader audience.